Eptifibatide
Eptifibatide
Eptifibatide (pronounced ep-ti-fib-a-tide) is a cyclic heptapeptide derived from a protein found in the venom of the southeastern pygmy rattlesnake (Sistrurus miliarius barbouri). It belongs to the class of anticoagulant drugs known as glycoprotein IIb/IIIa inhibitors.
Etymology
The name "Eptifibatide" is derived from the description of the drug: "Epti-" is a prefix meaning "derived from," "-fib-" refers to its ability to inhibit fibrinogen binding, and "-tide" is a common suffix for peptides.
Usage
Eptifibatide is used to prevent blood clots in people with certain heart conditions such as acute coronary syndrome and during percutaneous coronary intervention (PCI). It works by preventing blood platelets from sticking together and forming a clot.
Related Terms
- Acute coronary syndrome
- Percutaneous coronary intervention
- Glycoprotein IIb/IIIa inhibitors
- Anticoagulant
- Fibrinogen
- Peptides
See Also
External links
- Medical encyclopedia article on Eptifibatide
- Wikipedia's article - Eptifibatide
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski